For more than half a year after China’s Anbang “insurance” conglomerate mysteriously emerged out of nowhere, announcing its intentions to acquire US hotel chain Starwood, shortly before it even more mysteriously pulled its bid once questions about its source of funds emerged, Chinese M&A activity in the US was put in cryogenic sleep, with not e